The Role of Population Pharmacokinetics in Drug Development in Light of the Food and Drug Administration’s ‘Guidance for Industry: Population Pharmacokinetics’ Paul J. WilliamsEne I. Ette Leading Article 30 September 2012 Pages: 385 - 395
Clinical Pharmacokinetics of Pravastatin Tomomi Hatanaka Review Articles 30 September 2012 Pages: 397 - 412
Clinical Pharmacokinetics of Reboxetine, a Selective Norepinephrine Reuptake Inhibitor for the Treatment of Patients with Depression Joseph C. Fleishaker Review Articles 30 September 2012 Pages: 413 - 427
Clinical and Preclinical Pharmacokinetics of Raltitrexed Stephen J. ClarkePhilip J. BealeLaurent P. Rivory Review Articles 30 September 2012 Pages: 429 - 443
Monitoring Antiplatelet Therapy Debabrata MukherjeeDavid J. Moliterno Review Articles 30 September 2012 Pages: 445 - 458
Chiral Bioequivalence Joseph P. BoniJoan M. Korth-BradleyLeslie Z. Benet Original Research Article 30 September 2012 Pages: 459 - 469